ArticleCardiovascular endocrinology & metabolism2026
Proteomics analysis of empagliflozin in patients without diabetes or overt heart failure from empagliflozin and cardiac remodeling in people without diabetes CardioLink-7 randomized clinical trial.
Wei-Siang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.